Tag: FDA

Considerations for Accepting CBD Payments: “That’s a Lot of Compliance”

Last week, when Shopify announced it was allowing U.S. cannabidiol (CBD) sellers onto its platform, it cited a study predicting that the market would grow from $1.9 billion in 2018 to $20 billion by 2024.

High-risk Trends Series: Problematic Products

Dealing with high-risk portfolios adds complexity to a PF’s compliance efforts. This week, we begin an occasional series on the trends that are facing payment facilitators operating in the high-risk space.